PRINCETON, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing targeted immunotherapeutic drugs ...
Total Revenue of $560 million, exceeding guidanceCrysvita® revenue of $410 million and Dojolvi® revenue of $88 million2025 Financial ...
Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ETCompany ParticipantsSri Anantha - Vice President, ...
Achieved $479.0 million in AYVAKIT® (avapritinib) global net product revenues in 2024, including $144.1 million in the fourth quarter -- -- Anticipate global AYVAKIT ...
The voluntary effort by online platforms dates back to 2022, and sets out a range of commitments and measures to counter fake ...
Achieved $479.0 million in AYVAKIT® (avapritinib) global net product revenues in 2024, including $144.1 million in the fourth quarter -- -- Anticipate global AYVAKIT net product revenue of ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
The Nova Scotia government communications agency is being restructured to provide better integration between government policy, planning, operations and communications, says the minister responsible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback